Business Context and Reporting Period
This Form 8-K was filed by Avalo Therapeutics, Inc. on August 14, 2023. The filing addresses the extension of a forbearance agreement regarding a venture loan and a new dispute notice received from a licensing partner.
Key Financial Metrics
- Cash Position: Approximately $5.4 million in cash and cash equivalents as of August 11, 2023 (preliminary and unaudited).
- Debt Obligations: The company is subject to a Venture Loan and Security Agreement with institutional investors.
- Cash Deposit Requirement: Under the new agreement, the company must maintain a cash deposit of $3,000,000 in accounts subject to an Account Control Agreement.
- Disputed Liability: A notice alleges the company owes $837,522 to a service provider under a License Agreement.
Material Changes
- Extension of Forbearance: The forbearance period regarding an existing default on the venture loan was extended from August 15, 2023, to September 15, 2023.
- Modification of Cash Requirements: The requirement to deposit 100% of future equity sale proceeds into the controlled account was removed; the deposit is now fixed at $3,000,000.
- License Dispute: Apollo AP43 Limited initiated a formal dispute resolution process alleging a breach of the License Agreement dated July 29, 2022.
Outlook, Risks, and Contingencies
- Default Risk: The forbearance agreement remains in effect until September 15, 2023, or until a new default occurs. Failure to comply could trigger enforcement of remedies by lenders.
- Legal Contingency: The company intends to negotiate a settlement regarding the $837,522 alleged debt but noted that success is not guaranteed.
- Financial Uncertainty: The reported cash balance is preliminary and subject to change upon completion of financial statement closing and audit procedures.
Investor Verification Checklist
- Verify the final audited cash balance as of the most recent reporting period.
- Monitor the status of the dispute with Apollo AP43 Limited and any potential settlement terms.
- Confirm the company's ability to maintain the $3,000,000 cash deposit requirement through September 15, 2023.
- Review the full text of the Second Forbearance Agreement (Exhibit 10.1) for additional covenants.